Shares of PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.08 and traded as high as $0.16. PURE Bioscience shares last traded at $0.16, with a volume of 54,135 shares.
PURE Bioscience Trading Down 1.6 %
The stock has a 50-day moving average price of $0.08 and a two-hundred day moving average price of $0.08.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.47 million for the quarter.
About PURE Bioscience
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Read More
- Five stocks we like better than PURE Bioscience
- Are Penny Stocks a Good Fit for Your Portfolio?
- How Whitestone REIT is Transforming Sunbelt Retail Growth
- What is Insider Trading? What You Can Learn from Insider Trading
- Top-Performing Non-Leveraged ETFs This Year
- 3 REITs to Buy and Hold for the Long Term
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
